A significant shift is underway for many individuals relying on Medicaid, with a new final rule from the Trump administration now mandating that most beneficiaries between the ages of 19 and 64 demonstrate some form of work activity to continue receiving benefits. This rule, established under the framework of the “One Big Beautiful Bill Act,” outlines the requirements states must implement, detailing expectations for eligibility, exemptions, verification processes, and reporting obligations. Essentially, the core idea is that to receive Medicaid, individuals will need to prove they are either working, engaged in community service, or participating in an approved work program.
This sweeping policy change is a direct result of the significant tax and spending legislation passed by Congress, which incorporated these work requirements as a means to offset its substantial cost.… Continue reading
The Office of Personnel Management (OPM) has mandated that federal employee health insurance plans cease coverage for gender-affirming care for transgender individuals starting next year, threatening contract termination for non-compliance. This directive removes previously existing exceptions for those undergoing treatment, effectively ending all coverage for gender transition in these plans. These new restrictions impact over 11 million individuals, forcing them to pay out-of-pocket for necessary care or seek employment elsewhere, and represent a significant step in a wider effort to restrict transgender healthcare access.
Read More
Recent polling data paints a stark picture of Donald Trump’s presidency, suggesting he stands out as the worst of this century on a crucial issue. While discussions often expand to encompass his entire tenure and character, this specific data point focuses on a particularly weak performance, igniting considerable debate about his impact.
The criticism suggests a consistent pattern of poor decision-making and a fundamental lack of competence, extending beyond just one area. Many feel he has actively worked against the nation’s well-being, dismantling positive aspects and exacerbating existing problems. This perspective implies that his presidency was not merely a case of underperformance, but rather a deliberate choice of “worse decisions” when faced with alternatives.… Continue reading
As part of the administration’s crackdown on Medicaid fraud, Vice President JD Vance announced the withholding of $1.3 billion in Medicaid payments to California, citing the state’s perceived lack of seriousness in prosecuting fraud. This action follows a similar suspension of payments to Minnesota earlier in the year and serves as a warning to all states that federal funding to their Medicaid Fraud Control Units could be suspended if they do not aggressively pursue fraud. The administration is also scrutinizing specific expenditures in California, including $630 million in billing, $500 million in home health services, and $200 million in questionable expenditures related to undocumented immigrants, who are not eligible for Medicaid. In addition to these actions, the Centers for Medicare and Medicaid Services (CMS) has imposed a six-month moratorium on new Medicare enrollment for hospices and home health agencies to intensify investigations and remove suspected fraudulent providers.
Read More
Senate Republicans voted to reject an amendment proposed by Sen. Bernie Sanders that sought to halve prescription drug prices in the United States by tying them to rates in Canada and other wealthy nations. While this amendment garnered support from all present Democrats and two Republicans, its failure underscores a partisan divide on drug pricing policy. This action contrasts with a previous executive order from President Trump aimed at aligning US prices with international benchmarks, though its effectiveness was limited without congressional action. Sanders’ amendment proposed a “most-favored-nation” pricing model, reflecting a broader legislative effort to curb what are demonstrably higher prescription drug costs for Americans compared to other developed countries.
Read More
It’s disheartening to see opportunities to make healthcare more affordable for everyday Americans repeatedly shut down, especially when it seems so clear that this is an issue weighing heavily on people’s minds. The recent actions that have essentially struck down chances to lower healthcare costs paint a rather grim picture of priorities. It’s baffling, frankly, to witness proposals aimed at easing the financial burden of medical care being rejected.
The sentiment is that such decisions aren’t just political disagreements; they feel like a deliberate choice to prioritize other interests over the well-being of the average citizen. When funds are readily available for global military engagements or for lavish spending that benefits a select few, the inability or unwillingness to allocate resources towards making healthcare accessible and affordable for everyone back home raises serious questions.… Continue reading
During a Senate Finance Committee hearing, Health and Human Services Secretary Robert F. Kennedy Jr. defended President Trump’s claims of prescription drug price reductions by stating the president uses a unique calculation method. When pressed by Senator Elizabeth Warren on the mathematically impossible claims of 600% price cuts, Kennedy asserted that a reduction from $600 to $10 represents a 600% decrease. This statement drew criticism from mathematicians and highlighted how the TrumpRx website misleadingly promotes brand-name drugs at inflated prices, often with cheaper generic alternatives available, while pharmaceutical companies receive tariff exemptions. Further scrutiny revealed that most drugs on TrumpRx do not offer lower prices, and reports indicate upcoming price hikes on numerous medications.
Read More
Minnesota Governor Tim Walz has urged the next Democratic president to prioritize universal healthcare, emphasizing that retaining power should be for the purpose of enacting policy. This call comes amidst ongoing internal debate within the Democratic party regarding the merits and feasibility of such a system, with progressive voices like Senator Bernie Sanders advocating for “Medicare for All” while more moderate figures have expressed concerns about its cost. Public opinion, as indicated by recent polling, reveals a widespread sentiment that healthcare is unaffordable and a desire for a system where insurance is not tied to employment.
Read More
To encourage domestic manufacturing and secure access to life-saving medications, President Trump has imposed a 100% tariff on brand-name pharmaceuticals produced abroad. Drug companies that commit to relocating production to the U.S. will face a transitional 20% tariff, with the full tariff levied if production does not return to the U.S. within four years. Companies that also agree to lower prices to “most favored nation” levels will be exempt from tariffs, signaling the administration’s continued efforts to negotiate deals and incentivize U.S. investment in the pharmaceutical sector.
Read More
The Republican party is reportedly considering significant cuts to federal health spending as a means to finance a substantial budget bill, potentially amounting to as much as $200 billion. This funding is earmarked for a burgeoning conflict with Iran and for enhanced immigration enforcement efforts. This proposed reallocation of resources has ignited a firestorm of public reaction, highlighting a perceived stark contrast between priorities: potentially sacrificing domestic health well-being for military expenditure and border security.
This strategy, if enacted, would mean a reduction in healthcare services or increased costs for Americans, all to fund an war that many find unpopular. The idea of further diminishing healthcare access, especially after previous actions seen as detrimental to social safety nets, is being met with widespread disbelief and anger.… Continue reading
Matt Underwood 
John Q. Hosedrinker